- Home
- BLRX vs MXC Comparison
BLRX vs MXC Comparison
Compare BLRX & MXC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLRX
- MXC
- Stock Information
- Founded
- BLRX 2003
- MXC 1972
- Country
- BLRX Israel
- MXC United States
- Employees
- BLRX N/A
- MXC N/A
- Industry
- BLRX Biotechnology: Pharmaceutical Preparations
- MXC Oil & Gas Production
- Sector
- BLRX Health Care
- MXC Energy
- Exchange
- BLRX Nasdaq
- MXC Nasdaq
- Market Cap
- BLRX 12.1M
- MXC 13.3M
- IPO Year
- BLRX 2011
- MXC N/A
- Fundamental
- Price
- BLRX $3.09
- MXC $6.97
- Analyst Decision
- BLRX Buy
- MXC
- Analyst Count
- BLRX 2
- MXC 0
- Target Price
- BLRX $26.00
- MXC N/A
- AVG Volume (30 Days)
- BLRX 17.4K
- MXC 3.3K
- Earning Date
- BLRX 05-27-2025
- MXC 06-26-2025
- Dividend Yield
- BLRX N/A
- MXC 1.52%
- EPS Growth
- BLRX N/A
- MXC N/A
- EPS
- BLRX N/A
- MXC 0.63
- Revenue
- BLRX $28,940,000.00
- MXC $7,161,739.00
- Revenue This Year
- BLRX N/A
- MXC N/A
- Revenue Next Year
- BLRX N/A
- MXC N/A
- P/E Ratio
- BLRX N/A
- MXC $10.54
- Revenue Growth
- BLRX 502.92
- MXC 2.12
- 52 Week Low
- BLRX $2.30
- MXC $5.89
- 52 Week High
- BLRX $35.60
- MXC $14.11
- Technical
- Relative Strength Index (RSI)
- BLRX 44.89
- MXC 35.81
- Support Level
- BLRX $3.01
- MXC $6.41
- Resistance Level
- BLRX $3.25
- MXC $6.97
- Average True Range (ATR)
- BLRX 0.16
- MXC 0.37
- MACD
- BLRX -0.02
- MXC 0.10
- Stochastic Oscillator
- BLRX 0.13
- MXC 55.88
About BLRX BioLineRx Ltd.
BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has an off-strategy, legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.
About MXC Mexco Energy Corporation
Mexco Energy Corporation is an independent oil and gas company. It is engaged in the exploration, development, and production of natural gas and crude oil properties located in the United States. The company carried out its operation in the Permian Basin of West Texas. It is focusing on two primary areas, the Delaware Basin located in the Western portion of the Permian Basin including Lea and Eddy Counties, New Mexico and Loving County, Texas, and the Midland Basin located in the Eastern portion of the Permian Basin including Reagan, Upton, Midland, Martin, Howard, and Glasscock Counties, Texas. The company generates revenue from Oil sales, Natural gas sales, oil and gas royalty interests.